quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:02:41·1186d
FDARegulatory
Intersect ENT Inc. logo

FDA Approval for SINUVA issued to INTERSECT ENT INC

XENT· Intersect ENT Inc.
Health Care
Original source

Companies

  • XENT
    Intersect ENT Inc.
    Health Care

Recent analyst ratings

  • Aug 12UpdateSVB Leerink$28.25
  • Aug 10UpdateBTIG-
  • Aug 9UpdateCanaccord Genuity$28.25
  • Aug 9UpdateGuggenheim$28.25
  • Jun 24UpdateSVB Leerink$23.00

Related

  • SEC1319d
    SEC Form POSASR filed by Intersect ENT Inc.
  • SEC1319d
    SEC Form RW WD filed by Intersect ENT Inc.
  • PR1379d
    Nalu Medical, Inc. Names Thomas West President and Chief Executive Officer
  • SEC1431d
    SEC Form 15-12B filed by Intersect ENT Inc.
  • SEC1435d
    SEC Form S-8 POS filed by Intersect ENT Inc.
  • SEC1437d
    SEC Form EFFECT filed by Intersect ENT Inc.
  • INSIDER1438d
    SEC Form 4 filed by Hattangadi Neil A
  • INSIDER1438d
    SEC Form 4: Meier Richard A closing all direct ownership in the company
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022